American Portfolios Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$146K Buy
8,818
+52
+0.6% +$1.17K 0.01% 1150
2022
Q2
$174K Buy
8,766
+213
+2% +$4.3K 0.01% 1112
2022
Q1
$236K Buy
8,553
+653
+8% +$18.7K 0.01% 1079
2021
Q4
$325K Buy
+7,900
New +$349K 0.01% 923

Other funds holding VCYT

American Portfolios Advisors's VCYT Position: Q3 2022 in Review

American Portfolios Advisors increased its Veracyte (VCYT) stake by 0.59% in Q3 2022, buying an estimated $1.17K and bringing the position to 8,818 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #1150.

American Portfolios Advisors first reported a position in VCYT in Q4 2021 and has held it in 4 quarters since. The position peaked at $325K in Q4 2021. 208 funds tracked by Wall St. Rank hold VCYT as of Q3 2022.

  • American Portfolios Advisors held 8,818 shares of Veracyte worth $146K as of Q3 2022.
  • American Portfolios Advisors bought 52 Veracyte shares in Q3 2022, an estimated $1.17K.
  • Veracyte made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1150 holding.
  • American Portfolios Advisors first reported a position in Veracyte in Q4 2021 and has held it in 4 quarters since.
  • American Portfolios Advisors's Veracyte position peaked at $325K in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Veracyte as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.